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Introduction
Langerhans cells (LC) are members of  the DC family of  professional antigen presenting cells that are 
distinguished by their residence in the epidermis of  skin and mucosa, high expression of  CD1a (1), and 
unique expression of  langerin (CD207). As part of  the host innate immune system at the interface with 
the external environment, LC are equipped with endocytic receptors for phagocytosis (2, 3) and have a 
key role in antigen presentation to T cells (4). In response to cutaneous fungal infection, LC are required 
for T cell differentiation (5–7).
CD1a is part of  the human cluster of  differentiation 1 (CD1) gene family consisting of  a small 
number of  genes that are structurally related to the MHC class I genes (8); however, unlike MHC 
class I molecules, CD1 proteins are nonpolymorphic. The CD1a, -b, and -c molecules are more closely 
homologous to one another than to CD1d (8) and are absent in mice. In skin, CD1a and -c isoforms 
are present on the surface of  LC; whereas, CD1a, -b, and -c are expressed on dermal DC (9–11). 
CD1a-restricted T cell responses include autoreactive (12, 13) as well as against mycobacterial anti-
gens, including host-derived sulfatides (14), “headless antigens” (13), pollen phospholipids (15), and 
dideoxymycobactin (16). The crystal structure of  CD1a has been resolved with both sulfatide (17) 
and dideoxymycobactin (18), indicating the presence of  2 hydrophobic binding pockets A′ and F′. 
CD1a autoreactive T cells home to skin (19), recognizing CD1a loaded with skin-derived lipids (13), 
including — as we showed — lipids processed into free fatty acids (20), which allow direct interaction 
between the T cell receptor and CD1a (21).
DC, through the uptake, processing, and presentation of antigen, are responsible for activation 
of T cell responses to defend the host against infection, yet it is not known if they can directly kill 
invading bacteria. Here, we studied in human leprosy, how Langerhans cells (LC), specialized DC, 
contribute to host defense against bacterial infection. IFN-γ treatment of LC isolated from human 
epidermis and infected with Mycobacterium leprae (M. leprae) activated an antimicrobial activity, 
which was dependent on the upregulation of the antimicrobial peptide cathelicidin and induction 
of autophagy. IFN-γ induction of autophagy promoted fusion of phagosomes containing M. 
leprae with lysosomes and the delivery of cathelicidin to the intracellular compartment containing 
the pathogen. Autophagy enhanced the ability of M. leprae–infected LC to present antigen to 
CD1a-restricted T cells. The frequency of IFN-γ labeling and LC containing both cathelicidin and 
autophagic vesicles was greater in the self-healing lesions vs. progressive lesions, thus correlating 
with the effectiveness of host defense against the pathogen. These data indicate that autophagy 
links the ability of DC to kill and degrade an invading pathogen, ensuring cell survival from the 
infection while facilitating presentation of microbial antigens to resident T cells.
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Leprosy, an infection of skin caused by the intracellular pathogen Mycobacterium leprae (M. leprae), provides 
a model to study mechanisms of host defense against an intracellular bacterial pathogen at the site of infection. 
The disease presents as a spectrum, in which the clinical manifestations correlate with the ability of the immune 
response to contain the pathogen. There are increased numbers of CD1a+ LC, both in the epidermis and dermal 
granulomas of the skin lesions from the self-limiting tuberculoid (T-lep) form vs. the progressive lepromatous 
(L-lep) form of leprosy (9, 22, 23). LC have been shown to present M. leprae antigens to T cell clones derived 
from skin lesions of T-lep patients in a CD1a-restricted manner (24). Of relevance, the earliest lesions of leprosy 
are thought to arise in the epidermis (25), and LC have been shown to be infected by M. leprae (26).
There are several mechanisms by which CD1-restricted T cells contribute to host defense against myco-
bacterial infection (27–30). Some mycobacteria-specific group I CD1-restricted T cells secrete the Th1 pat-
tern of  cytokines (27), are cytolytic against infected targets (27, 31), and trigger antimicrobial activity (29, 
32). These antimicrobial T cells express perforin, granzyme B, and the antimicrobial protein granulysin in 
intracellular granules (29). Furthermore, the ability of  these T cells to release IFN-γ potentially leads to 
induction of  autophagy as well as the vitamin D–dependent antimicrobial response in monocytes and mac-
rophages, including upregulation of  the antimicrobial peptides CAMP and DEFB4 (encoding cathelicidin 
[Cath]/LL-37 and human β-defensin-2, respectively) (33–35). Autophagy is an evolutionarily conserved 
process in which eukaryotic cells break down cytoplasmic contents by usage of  the lysosomes during times 
of  low nutrients or starvation, often as a result of  an infection (36, 37). While it has been reported that 
suppression of  Cath during M. tuberculosis infection resulted in reduced levels of  autophagy in macrophages 
(38), the role of  Cath is still unclear in DC (39).
Although LC have been shown to mediate an antiviral activity (40–42), there is little evidence that 
LC contribute to antibacterial immunity, rather the opposite that LC contribute to progressive infection 
(3). Yet in order to fulfill their function as antigen presenting cells, it is reasonable to expect that DC 
such as LC can mount an antibacterial response in order to facilitate processing of  microbial antigens 
for presentation to T cells during active infection. Therefore, this work was undertaken to learn, through 
the study of  leprosy, whether LC were capable of  exerting an antimicrobial response with the ability to 
process bacterial-derived antigen for presentation to T cells.
Results
IFN-γ induced antimicrobial activity in LCDC and epidermal LC. Given the increased numbers of  LC in the 
epidermis of  T-lep vs. L-lep patients (9, 22, 23), we sought to determine whether LC could encounter IFN-γ 
in this location. Previously, IFN-γ mRNA was found to be more highly expressed in T-lep vs. L-lep lesions 
(43–45), yet it was unclear if  IFN-γ protein was present in the epidermis in these lesions. Here, we detected 
higher levels of  IFN-γ protein by immunoperoxidase and immunofluorescence in the epidermis of  T-lep 
vs. L-lep lesions, colocalizing with CD1a+ LC (Figure 1, A–C, and Supplemental Figure 1; supplemental 
material available online with this article; https://doi.org/10.1172/jci.insight.126955DS1).
IFN-γ is known to activate antimicrobial pathways to kill intracellular pathogens. We sought deter-
mine whether this cytokine could induce an antimicrobial activity in M. leprae–infected LC. LC-like DC 
(LCDC) were derived from CD34+ hematopoietic precursor cells, which have been used as surrogates for 
LC (Supplemental Figure 2A) (24, 41, 46). Electron microscopy of  LCDC confirmed the presence of  Bir-
beck granules, which are specific for LC (Supplemental Figure 2B). In addition, epidermal CD1a+ LC were 
also isolated from healthy skin (Supplemental Figure 2C) (6, 47). To establish whether M. leprae is able to 
infect LC in vitro, as this has not been demonstrated, LCDC and epidermal LC were cultured with live M. 
leprae at increasing multiplicities of  infection (MOI) of  5, 10, and 20 per cell. A MOI of  10 yielded approx-
imately 50% of  the cells infected with M. leprae, with approximately 3–5 bacilli per cell. Both LCDC and 
LC maintained cellular morphology (Supplemental Figure 3, A and B) and retained the expression of  the 
LC-specific marker CD207/langerin (Supplemental Figure 3C).
To measure the antimicrobial response of  LC against intracellular M. leprae, bacterial viability was mea-
sured according to the ratio of  bacterial 16S rRNA to repetitive element DNA using a PCR-based method 
(45, 48, 49), as the bacteria cannot be grown in culture. LCDC were infected with M. leprae, cultured with 10% 
human vitamin D–sufficient serum, and stimulated with either IFN-γ or media control. IFN-γ treatment of  
infected LCDC resulted in the induction of  significant antimicrobial activity vs. media control (83% ± 5%, 
P < 0.001; Figure 1D). Similarly, IFN-γ–treated CD1a+ epidermal LC induced a significant antimicrobial 
response against M. leprae (77% ± 4%, P < 0.001; Figure 1E). Conversely, IFN-γ treatment of  the CD1a– epi-
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dermal cells, which contained <10% LC, induced an approximately 6-fold lower antimicrobial response (12% 
± 2%, P < 0.03 of  CD1a+ vs. CD1-negative LC; Figure 1F), suggesting that the CD1a+ LC mount a more 
robust antimicrobial response. As a control, we treated M. leprae–infected LCDC with IL-4, a cytokine more 
highly expressed in L-lep lesions. This did not induce an antimicrobial response (Supplemental Figure 4).
IFN-γ induces autophagy and phagolysosomal fusion in M. leprae–infected LC. The ability of  M. leprae to block 
phagolysosomal fusion in macrophages prevents the delivery of  antimicrobial effector molecules from lyso-
somes into the phagosomes, which contain the invading bacteria (50–55). This blockade can be overcome by 
the cellular process of  autophagy, through the creation of  autophagosomes and their subsequent fusion with 
lysosomes (34, 35, 56–60). Because there is little information on the induction of  autophagy and its biological 
role in LC, we stimulated LCDC and epidermal LC with IFN-γ and the induction of  autophagy was assessed 
by LC3 aggregation. IFN-γ induced an increase LC3 aggregation in both LCDC and epidermal CD1a+ LC 
as compared with cells cultured with media control (Figure 2, A–D). LCDC had 18.6 ± 2 puncta per cell for 
IFN-γ treatment vs. 0.9 ± 0.3 LC3 puncta per cell for media treatment (P < 0.01; Figure 2B). Similarly, epider-
mal LC expressed 22.0 ± 1.9 puncta per cell for IFN-γ treatment as compared with 2.5 ± 0.7 LC3 puncta per 
cell for media treatment (P < 0.01; Figure 2D). The ability of  IFN-γ to induce autophagy was also evidenced 
by an increase in the percentage of  cells with LC3+ vesicles (Supplemental Figure 5, A and B), as well as the 
accumulation of  LC3-II protein resulting from the cleavage of  LC3-I precursor (Supplemental Figure 5C) 
(61). We also utilized acridine orange, a lysosomotropic dye, to quantify the IFN-γ–induced formation of  
acidic vesicular organelles (AVO) (Supplemental Figure 6A) (62, 63). Analogous to the number of  LC3 punc-
ta, IFN-γ induced more AVO puncta per cell than media treated LCDC, 19.0 ± 0.9 vs. 5.21.0 AVO per cell 
(P < 0.01; Supplemental Figure 6B). Electron micrograph revealed that IFN-γ stimulation of  LCDC induced 
a significant increase in the number of  electron-dense endolysosomes compared with media control: 22.1 ± 
1.2 vs. 7.7 ± 0.7 endolysosomes per cell (P < 0.01; Supplemental Figure 6, C and D). Utilizing the principles 
of  point counting (64), we quantified the cellular volume of  single-membrane and double-membrane com-
partments, the latter being a characteristic of  autophagosomes. LCDC treated with IFN-γ had higher dou-
ble-membrane volume than media control, 0.07 ± 0.01 μm3 vs. 0.02 ± 0.01 μm3 (P < 0.03), while the inverse 
was observed between the conditions with single-membrane volume (Supplemental Figure 6E).
We next investigated the effects IFN-γ–mediated phagosome maturation and phagolysosomal fusion 
during M. leprae infection. As compared with cells treated with media alone, IFN-γ treatment of  M. leprae–
infected LCDC induced autophagy as well as colocalization of  intracellular bacteria to the autophagosome, 
identified by LC3 aggregation and colocalization with the labeled M. leprae bacilli and further delineated 
by 3-dimensional modeling (Figure 2E). IFN-γ treatment of  LCDC also resulted in colocalization of  bacil-
li and LAMP1, a lysosome marker, indicating that the majority of  M. leprae bacilli were localized to the 
lysosome compartment (Figure 2F). Furthermore, IFN-γ stimulation of  M. leprae–infected LCDC triggered 
autophagolysosomal fusion, as evidenced by the colocalization of  the bacilli with LC3 and LAMP1 (Figure 
2G). By electron microscopy (EM), we confirmed that, in IFN-γ–treated LCDC, the M. leprae bacilli were 
contained within compartments surrounded by autophagosomes, characterized by double-membrane vesi-
cles. We also detected evidence by EM of IFN-γ–induced fusion between autophagosomes, characterized by 
double membranes and containing bacilli, with lysosomes. In contrast, the majority of  the intracellular bacilli 
in the control LCDC treated with media were contained in phagosomes with a single membrane (>90%; 
Figure 2H and Supplemental Figure 6F). Additionally, the mycobacterial cell walls were mostly intact in the 
media control–treated LCDC, while in IFN-γ–treated LCDC, the cells walls were often degraded and the 
bacilli lysed. Together, these data demonstrate that M. leprae blocks the inhibition of  autophagolysosomal 
fusion is overcome by IFN-γ activation, facilitating an antimicrobial response.
IFN-γ induces antimicrobial peptides in LC. IFN-γ can trigger an antimicrobial response against intracellular 
pathogens by a variety of  mechanisms, including the vitamin D–dependent generation of  antimicrobial pep-
tides CAMP and DEFB4 in monocytes and macrophages (33, 34). The addition of  IFN-γ was determined to 
be sufficient to induce the gene expression of  the antimicrobial peptides CAMP and DEFB4 in both LCDC 
(Figure 3A) and epidermal CD1a+ LC (Figure 3B). IFN-γ was also sufficient to induce Cath protein in LCDC 
as detected by confocal laser microscopy (Figure 3C and Supplemental Figure 7A). The percentage of  Cath+ 
cells was significantly greater in IFN-γ vs. media-treated LCDC (74% ± 2% vs. 4.9% ± 2.7% in media control, 
P < 0.002, Figure 3D). In contrast, β-defensin-2 protein expression was detected in CD1a+ LCDC treated with 
media and was not further induced by IFN-γ stimulation, suggesting that it is constitutively expressed (Supple-
mental Figure 7, B and C), consistent with its constitutive expression in the skin (65).
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IFN-γ induction of  Cath in infected LCDC resulted in the colocalization of  Cath with intracellular 
M. leprae. In IFN-γ–treated LCDC, Cath was detected surrounding intracellular bacilli and localized to 
the LAMP1+ lysosome (Figure 3E). In contrast, media treatment of  LCDC did not result in detectable 
Cath. Therefore, to determine the role of  Cath in LC-mediated antimicrobial activity against M. leprae, 
transfection of  siRNAs targeting Cath mRNA was used. Approximately 50% specific knockdown of  
Cath mRNA was achieved, affecting cell viability by <10% (Supplemental Figure 8A). Vitamin D recep-
tor (VDR) mRNA levels were unaffected by siRNA targeting Cath (Supplemental Figure 8B). In these 
experiments, the knockdown of  Cath reduced IFN-γ–induced antimicrobial activity from 77% ± 2% to 
29% ± 5% (P < 0.02), an approximately 60% reduction compared with IFN-γ paired with the small inter-
fering control (siCTRL) (Figure 3F). During M. leprae infection, Cath peptide was undetectable in media 
control–treated LCDC but was found to colocalize with M. leprae inside LAMP1+ vesicles when stim-
Figure 1. IFN-γ induces antimicrobial activity in Langerhans cells. (A) IFN-γ expression in leprosy lesions, tuberculoid 
(T-lep), and lepromatous (L-lep); 1 representative labeled section is shown out of 4 individuals at 20×. Scale bar: 30 
μm. (B) Ratio of IFN-γ and nuclear staining quantified by ImmunoRatio. Data are represented as mean ± SEM, n = 6 
IHC sections. (C) Colocalization of IFN-γ (green) and CD1a (red) in T-lep lesions. Data are representative of 3 individual 
T-lep or L-lep lesions at 63×. (D) Human LCDC were stimulated with recombinant IFN-γ for 4 hours, washed and infect-
ed with M. leprae at a MOI of 10 overnight, and washed and stimulated with rIFN-γ for an additional 4 days. Viability 
of M. leprae was calculated by the ratio of bacterial 16S RNA and DNA (RLEP) detected by qPCR, and percent increase 
or decrease relative to no treatment (media) was determined. Data are represented as mean ± SEM, n = 9. (E) Human 
primary CD1a+ epidermal cells or (F) CD1a– epidermal cells were stimulated with rIFN-γ for 4 hours and washed and 
infected with M. leprae as in D. Viability of M. leprae was calculated as described in D. Data are represented as mean ± 
SEM, n = 5. *P < 0.05, **P < 0.01. Two-tailed Student’s t test. 
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Figure 2. IFN-γ induces autophagy in Langerhans cells. (A) Human LCDC were cultured with rIFN-γ, rapamycin, or 
medium overnight in 10% vitamin D–sufficient human serum, and they were fixed and immunolabeled with anti-LC3 
antibody (green) and anti-CD207/langerin antibody (red). Nuclei were stained with DAPI (blue). Representative shown 
of 4 independent experiments. (B) The number of LC3 puncta per cell were quantified. Data are represented as mean 
puncta per cell ± SEM, n ≥ 30 cells. (C) Human primary CD1a+ LC were cultured and labeled as in A. Representative 
immunofluorescence images of 3 independent experiments are shown. (D) The number of LC3 puncta per cell were 
quantified. Data are represented as mean puncta per cell ± SEM, n ≥ 25 cells. (E–H) Human LCDC were stimulated 
with rIFN-γ for 4 hours, washed and infected with PKH26-M. leprae (red) at a MOI of 10 overnight, and washed and 
stimulated with rIFN-γ for an additional 4 hours. (E) Infected cells were fixed and immunolabeled with anti-LC3 anti-
body (green). Representative shown of 4 independent experiments. (F) Infected cells were fixed and immunolabeled 
with anti-LAMP1 antibody (green). Representative shown of 4 independent experiments. (G) Infected cells were fixed 
and immunolabeled with anti-LC3 antibody (green) and anti-LAMP1 antibody (cyan). Representative shown of 3 inde-
pendent experiments. (A, C, F, and G) Images captured on a 63× lens, with 6× zoom. (H) Infected cells were fixed and 
processed for electron microscopy. N, nucleus; L, lysosome. Black boxes labeled 1–4 correspond with magnifications 
shown. White arrows indicate single-membrane phagosomes. Yellow arrows indicate double-membrane autopha-
gosomes. Blue arrows indicate digested bacteria. Yellow asterisks indicate fusion of autophagosome with lysosome. 
Scale bars: 1 μm. Representative images of 3 independent experiments are shown. **P < 0.01. Repeated measures 
1-way ANOVA.
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ulated with IFN-γ (Figure 3, E and G). Correspondingly, the transfection of  siRNA oligos specific for 
Cath (siCath) prior to IFN-γ stimulation of  LCDC ablated Cath detection at both the protein and mRNA 
levels (Figure 3G and Supplemental Figure 8C). These data indicate that IFN-γ–induced antimicrobial 
activity in LC is dependent on the induction of  Cath.
Characterization of  LC in leprosy lesions. To investigate whether IFN-γ induction of  autophagy and Cath 
in LC was relevant at the site of  infection in leprosy, we utilized confocal microscopy. LC3 puncta were 
detected in CD1a+ LC in T-lep but not L-lep lesions, indicating the presence of  autophagic responses (Fig-
ure 4, A and B, and Supplemental Figure 9, A and B). Cath protein was ubiquitously expressed in the 
epidermis of  T-lep lesions and colocalized with CD1a+ LC. In contrast, in L-lep lesions, the expression of  
Cath was reduced (Figure 4, C–E, and Supplemental Figure 9, C and D). The isotype controls matching all 
monoclonal antibodies used for labeling were consistently negative (Supplemental Figure 9). Even though 
the confocal imaging demonstrated colocalization of  Cath with CD1a+ LC in T-lep lesions, we cannot dis-
tinguish if  the colocalization is due to cellular production or uptake from extracellular sources, given that 
Cath is known to be secreted (66). These data corroborate that skin-resident CD1a+ LC are in proximity to 
IFN-γ (Figure 1, A and B) and colocalize with Cath and autophagosomes, indicating the presence of  key 
components of  this antimicrobial pathway in LC at the site of  infection.
As part of  the DC family of  professional antigen presenting cells, LC are characterized by an enhanced 
ability to activate T cell responses. In skin, there is a resident T cell population that responds to micro-
bial antigens (67, 68). To study the resident T cell response against M. leprae, a CD1a-restricted T cell 
line, LCD4.G — derived from a T-lep skin lesion — was studied. LCD4.G is CD4+, expressing CD69 
and CD45RO but not CD103 or CD45RA, consistent with the T-resident memory (TRM) phenotype (Sup-
plemental Figure 10). Mycobacteria are known producers of  a variety of  lipids, which can form stable 
complexes with CD1 molecules and stimulate T cells (69, 70). To validate whether antigen presentation 
to LCD4.G T cells is CD1a dependent, we added CD1a blocking antibody to LCDC prior to the cocul-
ture with T cells. Anti-CD1a blocked the T cell response by about 80%, as compared with the addition of  
isotype control (Figure 5A). Supernatants, collected from LCD4.G after activation using anti-CD3/CD28 
antibodies, contained high levels of  IFN-γ (Figure 5B). When added to LCDC, the LCD4.G supernatants 
induced Cath and DEFB4 mRNAs. Neutralization of  IFN-γ by neutralizing mAbs significantly blocked 
the induction of  Cath and DEFB4 mRNA levels as compared with the isotype control (Figure 5C and 
Supplemental Figure 11A). Therefore, TRM cells, via the secretion of  IFN-γ, triggered the induction of  anti-
microbial peptides in LCDC. We also determined that the CD1a-restricted T cell clone LCD4.G triggered 
the IFN-γ dependent upregulation of  CYP27b1, VDR and CYP24A1 in LCDC (Supplemental Figure 11, 
B–D), components of  the vitamin D antimicrobial pathway.
In studying the role of  vitamin D in the LC response, we observed that the ability of  IFN-γ to induce 
autophagy was significantly greater in the presence of  vitamin D–sufficient sera or the addition of  1,25-dihy-
droxyvitamin D3 (1,25D3) to vitamin D–insufficient sera (Supplemental Figure 12, A–C). IFN-γ induction of  
Cath, DEFB4, and CYP24A1 mRNAs was dependent on activation of  the VDR in both primary epidermal 
LC (Supplemental Figure 13A) and LCDC (Supplemental Figure 13C). The addition of  VDR antagonist ZK 
159 222 (VAZ) significantly inhibited the induction of  these vitamin D–dependent genes. The induction of  
Cath also required the presence of  adequate levels of  25-hydroxyvitamin D (25D), as treatment of  IFN-γ in 
10% FCS, which had low 25D concentrations and was unable to induce gene expression (Supplemental Fig-
ure 14A) but could be rescued with the addition of  25D or bioactive 1,25D3 (Supplemental Figure 14C). The 
levels of  vitamin D did not affect IFN-γ induction of  the vitamin D–independent gene CD64 (Supplemental 
Figure 13, B and D, and Supplemental Figure 14B). Conversely, the IFN-γ–induced antimicrobial response 
was vitamin D dependent, such that even in 25D-insufficient sera, the antimicrobial activity could be restored 
by in vitro supplementation with 25D (Supplemental Figure 15, A and B). The data indicate that IFN-γ induc-
tion of  an antimicrobial response in LC is dependent on 25D levels.
Role of  autophagy in LC function. In human macrophages, autophagy can be triggered by a vitamin D–depen-
dent pathway (34, 71, 72), contributing to an antimicrobial response. In contrast, in DC, autophagy is recognized 
to contribute to effective antigen presentation to T cells by delivering antigen into antigen processing compart-
ments (73, 74). This led us to hypothesize that autophagy may be a conserved mechanism by which DC, such 
as LC, link antimicrobial activity to efficient presentation of microbial antigens to T cells. To investigate the role 
of autophagy in LC function, we used the phosphatidylinositol 3-kinase (PI3K) inhibitor wortmannin to block 
IFN-γ–induced autophagy (Figure 6A). The addition of wortmannin prior to IFN-γ stimulation significantly 
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reduced the number of accumulating LC3 puncta, from 19.3 ± 2.9 puncta to 5.3 ± 1.0 puncta (P < 0.01; Figure 
6B). Similarly, the percentage of LC3+ cells was also reduced in the presence of wortmannin (Supplemental 
Figure 16). The IFN-γ–induced antimicrobial activity in M. leprae–infected LCDC was dramatically inhibited by 
approximately 75% by the addition of wortmannin (Figure 6C), and by about 50% by the knockdown of ATG5 
(Figure 6D), indicating that induction of autophagy is required for optimal antimicrobial activity.
LC, by their proximity to the external environment, deal with microbial pathogens as they invade via 
the skin. LC express C-type lectins and other endocytic receptors that mediate the phagocytosis of  various 
microbes (2, 3) subsequently instruct the adaptive T cell response (5–7). There is evidence that LC mediate an 
antiviral response (40, 41); however, little is known about the ability of  LC, or DC in general, to kill such bac-
teria and fungi as part of  the innate immune response. Given that Staphylococcus aureus, Streptococcus pyogenes, 
Figure 3. Cathelicidin is involved in antimicrobial activity. Human LCDC were stimulated with rIFN-γ in 10% vitamin D–sufficient human serum. 
Cathelicidin and DEFB4 gene expression was assessed by qPCR. (A) LCDC data are represented as mean fold change ± SEM, n = 8. (B) Human prima-
ry CD1a+ LC data are represented as mean fold change ± SEM, n = 7. (C) Human LCDC were stimulated with rIFN-γ, fixed, and immunolabeled with 
anti-cathelicidin antibody (green) and anti-CD1a antibody (red). Representative shown of 4 independent experiments. (D) The percentage of cathelici-
din+ cells was determined. Data are represented as mean ± SEM, n = 4. (E) Human LCDC were stimulated with rIFN-γ for 4 hours, washed and infected 
with PKH26-M. leprae (red) at a MOI of 10 overnight, and washed and stimulated with rIFN-γ for an additional 4 hours. Infected cells were fixed and 
immunolabeled with anti-cathelicidin antibody (green) and anti-LAMP1 antibody (cyan). Nuclei were stained with DAPI (blue). Overlay of PKH26–M. 
leprae and cathelicidin, without LAMP1, shown in boxed inset. Representative shown of 4 independent experiments. (F and G) Human LCDC were 
transfected with siRNA oligos specific for cathelicidin (siCath) or nonspecific (siCTRL) and then treated with rIFN-γ in 10% human vitamin D–sufficient 
serum for 4 hours, washed and infected with M. leprae overnight, and washed and transfected with siRNA oligos and rIFN-γ for an additional 4 days. 
(F) Viability of M. leprae was calculated, and percent increase or decrease relative to no treatment (media) was determined. Data are represented as 
mean ± SEM, n = 4. (G) Following overnight infection with PKH26-M. leprae (red) overnight, LCDC were washed and stimulated with siRNA oligos and 
rIFN-γ for an additional 4 hours and immunolabeled with anti-cathelicidin antibody (green) and anti-LAMP1 antibody (cyan). Representative shown of 
3 independent experiments. (C, E, and G) Images captured on a 63× lens, with 6× zoom. *P < 0.05, **P < 0.01. Two-tailed Student’s t test (A, B, and D) 
or repeated measures 1-way ANOVA (F).
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and C. albicans are frequent skin pathogens, we infected LCDC and/or LC with these organisms and deter-
mined whether IFN-γ induced an antimicrobial response. IFN-γ reduced the viability in S. aureus–infected 
primary LC by about 60% (Figure 6E). Furthermore, we found that the induction of  autophagy by IFN-γ was 
crucial in limiting the growth of  S. aureus, S. pyogenes, and C. albicans in infected LCDC (Figure 6, F and G).
Because autophagy has been shown to enhance MHC class I– and MHC class II–restricted antigen 
presentation (53, 54), we investigated whether IFN-γ–induced autophagy in LC, which reduces bacterial via-
bility, would augment CD1a-restricted antigen presentation of  live bacilli. We verified that the treatment of  
LCDC with IFN-γ did not have a substantial effect on the expression of  CD1a, regardless of  the concentra-
tion of  25D or 1,25D in the culture (Supplemental Figure 17, A–F). In addition, the expression of  CD1a and 
HLA-DR were not substantially affected by infection of  LCDC with M. leprae (Supplemental Figure 17, G 
and H). Next, LCDC were infected with live M. leprae and cocultured with the CD1a-restricted T cell clone 
LCD4.G using a suboptimal number of  antigen presenting cells in order to measure augmentation. IL-2 was 
used as a positive control to demonstrate proliferative response by LCD4.G (Supplemental Figure 18). IFN-γ 
stimulation enhanced antigen presentation by primary human epidermal LC and LCDC, resulting in over a 
3-fold increase in T cell proliferation compared with antigen alone. The inhibition of  IFN-γ–induced auto-
phagy by wortmannin resulted in an approximately 80% decrease of  the T cell response (Figure 7, A and B). 
In comparison, monocyte-derived macrophages (MDM), which did not express CD1a (Supplemental Figure 
19) and lack a consensus matching MHC class II allele (Supplemental Table 1), did not present live M. leprae 
to the CD1a-restricted LCD4.G T cells (Figure 7C). These data indicate that autophagy is required for the 
ability of  LC to efficiently present antigen from live M. leprae to T cells. Together, these findings indicate that 
resident LC in skin are essential in promoting adaptive TRM responses during bacterial infection.
Figure 4. Langerhans cells in leprosy lesions. (A) LC3 expression in leprosy lesions (T-lep and L-lep); 1 representative labeled section is shown out of at 
3 individuals at 20×. Scale bar: 30 μm. (B) Colocalization of LC3 (green) and CD1a (red) in T-lep lesions at 63×. Three-dimensional modeling of corre-
sponding cells in white boxes. Data are representative of 3 individual T-lep or L-Lep samples. (C) Cathelicidin expression in leprosy lesions (T-lep and 
L-lep); 1 representative labeled section is shown out of at 4 individuals at 20×. Scale bar: 30 μm. (D) Ratio of cathelicidin and nuclear staining quanti-
fied by ImmunoRatio. Data are represented as mean ± SEM, n = 4 IHC sections. (E) Colocalization of cathelicidin (green) and CD1a (red) in T-lep lesions. 
Data are representative of 4 individual T-lep or L-Lep samples at 63×.
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Discussion
In primitive eukaryotic organisms such as yeast and amoebas, autophagy has an essential role in cell survival 
by managing the flow of nutrients and by clearing damaged organelles (75, 76). It has become increasingly 
clear that more complex organisms have evolved to utilize autophagy for other physiologic pathways, includ-
ing host defense, by bringing phagocytized microbial pathogens to lysosomes where they are destroyed. How-
ever, it is not known whether the ability of  autophagy to facilitate antigen presentation by DC is linked to an 
antimicrobial response. Here, we provide evidence that, in LC, which are resident DC at the interface of  the 
skin with the outside environment, autophagy delivers bacterial pathogens to lysosomes, where they are killed 
and subsequently processed into cognate antigens facilitating T cell recognition. These data suggest that auto-
phagy is a critical mechanism allowing DC to survive invasion by a microbial pathogen via an antimicrobial 
response, which contributes to efficient antigen presentation to T cells.
A major function of DC is to bridge the innate and adaptive immune response through the efficient pre-
sentation of antigen to T cells. The ability of DC to optimally present antigen via MHC class II is enhanced by 
the induction of autophagy, as shown in murine models of infection including HSV-1 (77, 78), influenza (79), 
and mycobacteria (73, 80). Induction of autophagy in human DC, albeit derived from monocytes differentiated 
with GM-CSF and IL-4, enhanced MHC class II presentation of HIV-1 (81) and the C-fragment of tetanus 
toxin expressed by salmonella (74). Here, we found that IFN-γ, by inducing autophagy in M. leprae–infected 
LC, enhanced CD1a-restricted antigen presentation of live M. leprae to a CD4+ T cell line, LCD4.G, derived 
from the TRM population in a leprosy skin lesion. Furthermore, LC are highly specialized in their function; 
while IFN-γ induced autophagy and antimicrobial activity against mycobacteria in both human LC and mac-
rophages (34, 45), only LC were equipped to present M. leprae antigen to the CD1a-restricted T cells. LC are 
not only involved in the presentation of microbial antigens to TRM, but also present self-antigens to skin-homing 
T cells via CD1a (19), including skin-derived lipids (13) and free fatty acids (20). Further studies are needed to 
define the role of autophagy in the different pathways by which LC present antigen to T cells.
Mycobacteria are known to inhibit phagolysosomal fusion (50–55) in macrophages, which is overcome 
by autophagy (34, 35, 56–60). In infected human LC, as in macrophages, IFN-γ induction of  autophagy 
and subsequent phagolysosomal fusion is required for an antimicrobial activity (34). IFN-γ also induces 
the vitamin D–dependent production of  Cath in LC, which is delivered to phagolysosomal compartments 
containing M. leprae and is required for the antimicrobial response. Autophagy components may also con-
tribute to host defense via other pathways (82). There are few studies indicating that DC mount an antimi-
crobial response against an intracellular pathogen (40, 83), with one report indicating that the induction of  
autophagy enhances antimicrobial function (84). It was recently reported that HIV infection induces auto-
Figure 5. The role of autophagy in Langerhans cells. (A) Human LCDC were stimulated with rIFN-γ for 4 hours, washed, and infected with M. leprae at a 
MOI of 10 overnight; washed and stimulated with rIFN-γ, with or without blocking anti-CD1a; and cultured with CD4+ T cells LCDC4.G, which were isolated 
from a T-lep lesion. T cells were pulsed with 3H-thymidine after 4 days of culture. Cells were harvested, and 3H incorporation was measured by a scintilla-
tion counter. Data are represented as mean ± SEM of triplicate cultures, n = 6. (B) CD4+ TRM cells secreted IFN-γ upon activation. CD4+ T cells (LCD4.G) were 
stimulated overnight by CD3/CD28 DynaBeads (TAct) or cultured in media alone (TRest), supernatants were collected, and IFN-γ was measured by sandwich 
ELISA. Data are represented as mean ± SEM, n = 4. (C) Human LCDC were cultured with T cell supernatants (TRest and TAct) in the presence or absence of an 
IFN-γ blocking mAb or isotype control antibody in 10% human vitamin D–sufficient serum. Cathelicidin gene expression was assessed by qPCR. Data are 
represented as mean fold change ± SEM, n = 3. *P < 0.05, **P < 0.01. Two-tailed Student’s t test or repeated measures 1-way ANOVA.
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phagy in LC, resulting in the trafficking of  the virions into the autophagosome for degradation (42). One 
major limitation of  our study is that we are unable to assess the in vivo role of  autophagy in the immune 
response to M. leprae, as there is no animal model that mimics the disease spectrum of  human leprosy. Also, 
it is not clear whether vitamin D is required for IFN-γ–induced autophagy in mouse macrophages and DC. 
Although IFN-γ induction of  autophagy is vitamin D dependent, it is not clear if  this is true in mouse mac-
rophages. However, our data provide insight into the role of  autophagy-induced antimicrobial activity in 
DC function, suggesting that this host defense pathway also results in the breakdown of  the pathogen into 
cognate antigen for optimal activation of  T cell responses.
We speculate that the ability of DC, such as LC, to mount this antimicrobial response not only contributes 
to enhanced antigen presentation, but may also represent a multifaceted survival mechanism. We found that 
IFN-γ induced autophagy-dependent antimicrobial activity in LC against other cutaneous pathogens, including 
S. aureus, S. pyogenes, and C. albicans. Whereas in macrophages, autophagy only contributes to the destruction 
Figure 6. Autophagy is essential for antimicrobial response. (A) LCDC were cultured with rIFN-γ, with pretreatment of wortmannin (WM) or DMSO 
(MED) and immunolabeled with anti-LC3 antibody (green). Nuclei were stained with DAPI (blue). Representative shown of 4 independent experi-
ments. Images captured on a 63× lens, with 6× zoom. (B) The number of LC3 puncta per cell were quantified. Data are represented as mean puncta 
per cell ± SEM, n ≥ 30 cells. (C) LCDC were stimulated with rIFN-γ, with pretreatment of WM or DMSO, and infected with M. leprae with a MOI of 10; 
they were stimulated with rIFN-γ, with treatment of WM or DMSO for an additional 4 days. Viability of mLEP was detected by qPCR, and percent 
increase or decrease relative to media was determined. Data are represented as mean ± SEM, n = 5. (D) LCDC were transfected with siRNA oligos for 
ATG5 (siATG5) or nonspecific (siCtrl) and then treated with rIFN-γ, followed by M. leprae infection overnight, and transfected with siRNAs and rIFN-γ. 
Viability of mLEP was calculated as in C. Data are represented as mean ± SEM, n = 4. (E) Primary CD1a+ LC were stimulated with rIFN-γ and washed 
and infected with S. aureus at a MOI of 3. Data are represented as mean ± SEM, n = 4. (F) LCDC were stimulated with rIFN-γ, with pretreatment of 
WM or DMSO for 4 hours, and infected with S. aureus (left) or S. pyogenes (right) at a MOI of 3. Data are represented as mean ± SEM, n = 5. (G) LCDC 
were stimulated with rIFN-γ, with pretreatment of WM or DMSO, and infected with C. albicans at a MOI of 3. Viability was quantified by CFU assay 
for E–G. Data are represented as mean SEM, n = 5. *P < 0.05, **P < 0.01. Repeated measures 1-way ANOVA.
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of such microbes (85–88), our data show that autophagy contributes both to an antimicrobial response in LC, 
which then allows DC to process and present pathogen-derived antigens to T cells, as well as to instruct the 
nature of the adaptive T cell response (5–7). The present findings are relevant to host defense at the site of infec-
tion, as the LC in leprosy lesions colocalized with IFN-γ exhibited an autophagic response and contained Cath 
protein. Finally, skin-derived LC were able to process and present live M. leprae to a TRM cell line derived from a 
leprosy lesion, resulting in the release of IFN-γ, providing an amplification loop to further augment autophagy, 
antimicrobial activity, and antigen presentation essential for effective immunity at sites of infection. In summary, 
these results provide evidence that LC contribute to host defense against cutaneous pathogens.
Methods
Reagents. Recombinant human IFN-γ was purchased from R&D Systems and used at a concentration of  
10 ng/ml. Both 25(OH)D3 and 1,25D3 were purchased from BioMol, dissolved in ethanol, and used at a 
concentration of  1 × 10–7M. VAZ was obtained from Bayer Schering Pharma AG and used at 1 × 10–9 M. 
Wortmannin, dissolved in DMSO and used at 500 nM; rapamycin, dissolved in DMSO and used at 300 
nM; poly-L-lysine; and saponin were purchased from MilliporeSigma. RPMI cell culture media, IMDM 
cell culture media, Hyclone FCS, CD3/CD28 Dynabeads, DAPI antifade with prolong Gold, Lipofect-
amine RNAiMAX, and TRIzol were purchased from Invitrogen. CD3/CD28 DynaBeads were used at 
bead/cell ratio of  1:1. Monoclonal antibodies and their corresponding isotype controls used were the 
following: anti-IFN-γ (clone B27, IgG1
κ
), APC anti–human CD1a (clone HI149, IgG1
κ
), PE anti–human 
CD80 (clone L307.4, IgG1
κ
), PE anti–human CD86 (clone IT2.2, IgG2b
κ
), and PE anti–human HLA-
DR (clone Tu39, IgG2a
κ
) were purchased from BD Biosciences. Purified anti–human CD1a (clone SK9, 
IgG2b
κ
), purified anti–human CD207/langerin (clone 4C7, IgG2a), and Alex647 anti–CD107/LAMP1 
(clone H4A3, IgG1
κ
) were obtained from BioLegend. PE anti-CD207/langerin (clone DCGM4, IgG1
κ
) 
was purchased from Beckman Coulter. Purified anti–human LC3 (clone 4E12, IgG1
κ
) was obtained 
from MBL International. Anti-Cath (clone OSX12, IgG1
κ
) and anti–β-defensin-2 (rabbit polyclonal 
EPR20469) were purchased from Abcam. CD1a magnetic beads were purchased from Miltenyi Biotec. 
Recombinant IL-2, used at 1 nM, were from Chiron Diagnostics. Recombinant GM-CSF was obtained 
from Genzyme Corporation, a Sanofi company.
Generation of  LCDC. CD34+ cells were cultured in RPMI in the presence of  SCF (25 ng/ml), GM-CSF 
(100 ng/ml), and TNF-α (500 ng/ml). At day 9, CD14+ cells were depleted from the culture. The remaining 
CD14– cells were replated in the presence of  GM-CSF (100 ng/ml) and TGF-β1 (1ng/ml) to increase CD1a 
expression. LCDC were harvested at day 13–15 and enriched for CD1a by using anti-CD1a magnetic 
Figure 7. Autophagy contributes to M. leprae antigen presentation to T cells. (A) Human primary CD1a+ LC were stimulated with rIFN-γ, with 
pretreatment of wortmannin (WM) or DMSO (MED) for 4 hours; washed and left uninfected (MED) or infected with M. leprae (mLEP) at a MOI of 10 
overnight; washed and stimulated with rIFN-γ, with wortmannin (WM) or DMSO (MED); and cultured with LCDC4.G. T cells were harvested after 4 
days, and 3H incorporation was measured by a scintillation counter. Data are represented as mean ± SEM of triplicate cultures, n = 4. (B) Human LCDC 
or (C) monocyte-derived macrophages (MDM) were stimulated, infected, and cultured with LCD4.G T cells as in A. LCD4.G cells were cultured with rIL-2 
as positive control. Data are represented as mean ± SEM of triplicate cultures. LCDC, n = 10; MDM, n = 4. *P < 0.05, **P < 0.01. Repeated measures 
1-way ANOVA. 
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beads. Of  the CD1a+ LCDC, 80%–90% were found to also be CD207+, by surface staining.
Preparation of  human LC. Epidermal cell suspensions were prepared from deidentified normal human skin 
taken from patients undergoing abdominal plastic surgery at UCLA Division of  Plastic and Reconstructive 
Surgery with the approval of  UCLA Tissue Procurement Core Laboratory, as previously described (6, 47). 
The attached adipose and connective tissues were removed, and the skin was cut in approximately into 0.5 
cm2 pieces, which were rinse in HBSS (Thermo Fisher Scientific) without calcium, magnesium, or phenol 
red. Skin pieces were then incubated in 0.2% dispase HBSS. The epidermis was separated from the dermis, 
mechanically separated into a single cell suspension, and filtered through 40-μm cell strainers (BD Bioscienc-
es). CD1a+ LC were isolated from the epidermal cell suspension by using anti-CD1a magnetic beads. Of the 
CD1a+ LC, 50% were found to also be CD207+ by surface staining. Epidermal LC were cultured in IMDM.
Human serum collection and 25D quantification. Blood was collected from healthy donors in the absence 
of  anticoagulants and allowed to clot for 2 hours. The serum layer was collected and passed through a 0.22-
μm filter and frozen in small aliquots at –80°C for future use. The concentration of  25D was determined 
by radioimmunoassay, as previously described (33, 89). Serum was pooled from several donors to obtain 
vitamin D–sufficient and vitamin D–insufficient batches. The 25D level in the vitamin D–sufficient pooled 
serum batches was approximately 100 nM (40 ng/ml), and in the vitamin D–insufficient serum, batches 
less than 35 nM (14 ng/ml). The 25D level in the FCS was less than 18 nM or 7 ng/ml.
LCDC and epidermal LC culture for PCR. Following CD1a selection, cells were cultured in 10% FCS or 
10% human serum, with or without 10% final volume of  T cell supernatants, as indicated. IFN-γ–induced 
gene expression of  CYP27B1, VDR, CYP24, Cath, and DEFB4 mRNAs were detected after 2 hours.
PCR. mRNA was isolated from cells using TRIzol according to the manufacturer-recommended pro-
tocol. cDNA was prepared and gene expression levels were measured by quantitative PCR (qPCR) and 
calculated by the 2–(ΔCt) method. Primer sequences for human Cath, DEFB4, CYP27B1, VDR, CYP24A1, 
human 36B4, CD64, and 16S rRNA and M. leprae–specific repetitive element (RLEP) of  M. leprae were 
previously reported (33, 34, 48).
siRNA transfection of  LCDC. Cath siRNA, ATG5 siRNA, and siCTRL, obtained from GE Dharmacon, 
were incubated with Lipofectamine RNAiMAX (Invitrogen) for 30 minutes to allow complexing. Then, 
siRNA was added to the LCDC culture at 200 pM, per transfection, 30 minutes and overnight prior to the 
addition of  IFN-γ for Cath siRNA and ATG5 siRNA, respectively.
Infection of  epidermal LC and LCDC, treatment with IFN-γ, and quantification of  antimicrobial activity. M. lep-
rae was grown in the footpad of  nu/nu mice, as described previously (90), and was provided by the Nation-
al Hansen’s Disease Program (Baton Rouge, Louisiana, USA). LCDC were pretreated with 10 ng/ml of  
IFN-γ or IL-4 in 10% human serum for 4 hours or overnight. The cells were washed prior to the overnight 
infection with M. leprae at a multiplicity of  infection (MOI) of  10 in 10% FCS. Extracellular bacteria were 
removed by vigorous washing. The infected cells were then treated again with the same concentration of  
IFN-γ or IL-4 in 10% human serum and harvested after 4 days. Epidermal LC were treated with IFN-γ and 
infected with mLEP similarly as above. RNA and DNA were isolated from infected cells following TRIzol 
protocol. The viability of  intracellular M. leprae was determined by qPCR and quantified as previously 
described (45, 48, 49). Briefly, cDNA was synthesized from the total RNA as described for both human and 
bacterial mRNAs. The M. leprae 16S rRNA and genomic element DNA (RLEP) levels were then assessed 
using real-time PCR. In order to normalize for the total number of  LC present in culture, 36B4 was also 
evaluated. Comparison of  the bacterial DNA to the mammalian 36B4 levels was used to monitor infectivity 
between all the conditions in the assay, as well as PCR quality. The 16S rRNA and genomic DNA values 
were calculated using the ΔΔCT analysis, with the bacterial DNA value serving as the housekeeping gene. 
The efficiency of  infection was determined by confocal microscopy and FACS. Approximately 45%–60% 
of  cells were infected. Cells viability following washes and infection was 81%–87% of  the total cells.
Intracellular killing of  S. aureus and S. pyogenes by LCDC and epidermal LC. S. aureus strain DU5938 (Hla−Hl-
b−Hlg−) (91) or S. pyogenes (ATCC 700294) (92) were grown to the mid-log phase at 37°C with shaking (150 
rpm) in brain-heart infusion (BHI) medium, collected by centrifugation for 10 minutes at 5,000 g. For cellular 
infection, the bacterial suspension was diluted with sterile 1× PBS. The number of  viable bacteria was deter-
mined by serial dilution and plating onto BHI agar plates (93). LCDC or epidermal LC (5 × 106 cells) were 
plated in 24-well plate at 1 ml and infected with S. aureus at MOI of  3 for 3 hours in 10% FCS antibiotic-free 
media. Next, 100 μg/ml of  gentamycin was added to the wells for 20 minutes to kill extracellular bacteria. 
Cells were then washed to further remove any remaining extracellular bacteria. Infected cells were cultured 
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overnight in 10% human serum with or without IFN-γ at 37°C in a 4% CO2 incubator (Thermo Scientific 
Midi 40 Small Capacity CO2 Incubator). To measure intracellular killing of  bacteria, cells were pelleted and 
lysed with 100 μl of  0.2% saponin in 1× PBS on ice for 20 minutes. PBS 1×, 900 μl, was added to bring the cell 
lysate to 1 ml final volume, of  which 1 μl was plated overnight and CFU was determined.
Antifungal activity. Candida albicans (ATCC 18804) were grown by agitation overnight at 28°C in yeast mold 
(YM) media. The cells were then washed twice with 1× PBS before use as live yeasts (94). LCDC (5 × 106) were 
plated in 24-well plates at 1 ml and infected with C. albicans at MOI of 3 for 3 hours in 10% FCS antibiotic-free 
media at 37°C. Amphotericin B (1 μg/ml) was added to wells for 20 minutes to kill extracellular C. albicans. 
Cells were then washed to further remove any remaining extracellular C. albicans. Infected cells were cultured 
overnight in 10% human serum with or without IFN-γ at 37°C in a 4% CO2 incubator (Thermo Scientific Midi 
40 Small Capacity CO2 Incubator). To measure antifungal activity, cells were pelleted and lysed with 100 μl of  
0.2% saponin in 1× PBS on ice for 20 minutes. PBS 1×, 900 μl, was added to bring the cell lysate to 1 ml final 
volume, of which 1 μl was plated for CFU at room temperature. Colonies were counted after 2 days.
Patients and clinical specimens. Patients with leprosy were classified according to the criteria of  Ridley and 
Jopling (95). The designation of  T-lep included patients who were classified clinically as borderline tubercu-
loid (BT), and the designation of  L-lep only included patients classified as “LL” (lepromatous leprosy). All 
T-lep and L-lep skin biopsy specimens were taken at the time of  diagnosis, prior to initiating treatment. Spec-
imens were embedded in OCT medium (Ames), snap frozen in liquid nitrogen, and stored at –80°C.
Tissue immunoperoxidase labeling. Frozen tissue sections were blocked with normal horse serum before 
incubation with mAbs for LC3, Cath, and IFN-γ for 60 minutes, followed by incubation with biotinylated 
horse anti–mouse IgG (see Reagents above) for 30 minutes. Slides were counterstained with hematoxy-
lin and mounted in crystal mounting medium (Biomeda) and were visualized using the ABC Elite sys-
tem (Vector Laboratories). Skin sections were examined using a Leica microscope (Leica). Ratios were 
calculated by ImmunoRatio online software (Jorma Isola & Vilppu Tuominen – Institute of  Biomedical 
Technology, University of  Tampere, Tampere, Finland) (96), an automated image analysis application that 
calculates the percent diaminobenzidine-stained (DAB-stained) nuclear area per total area.
Cell culture immunofluorescence labeling. Cells were treated with IFN-γ or left untreated in 10% human 
serum or 10% FCS overnight. Then, cells were washed and infected with live M. leprae (mLEP) at a MOI 
of  10 overnight and further stimulated with IFN-γ in 10% human serum for 3 hours. Following stimulation 
or infection, cells were adhered to poly-L-lysine–coated slides for 1 hour. Cells were then washed and fixed 
for 30 minutes with 4% PFA before being washed again. Next, cells were permeabilized with 0.25% sapo-
nin for 20 minutes, blocked with serum for 30 minutes, and immunolabeled with primary antibodies for 
LC3, CD1a, CD207, Cath, or DEFB4 for 2 hours. Following washing, cells were stained with secondary 
antibodies (see Reagents above) for 90 minutes, washed, and mounted with DAPI. For the quantification 
of  autophagy, the number of  puncta per cell and the percentages of  LC3 punctated cells, as defined the 
presence of  >5 puncta per cell, were evaluated using florescence microscopy and quantified by Imaris and 
Image J (NIH). Approximately 50–100 cells, over 6 different random fields of  view, were scored for each 
condition of  each experiment. Rapamycin was used as a positive control for autophagy induction, and 
wortmannin was used to inhibit autophagy. DMSO used as vehicle control in all media conditions.
Immunofluorescence of  cell cultures was examined using a Leica-TCS-SP MP inverted single confocal 
laser-scanning and a 2-photon laser microscope (Leica) at the Advanced Microscopy/Spectroscopy Lab-
oratory Macro-Scale Imaging Laboratory (California NanoSystems Institute, UCLA). Three-dimensional 
modeling of  microscopy images were generated by Imaris software.
Tissue immunofluorescence labeling. Immunofluorescence was performed by serially incubating cryostat tissue 
sections with anti-human mAbs of different isotypes for 2 hours and washed 3 times with 1× PBS, followed by 
incubation with isotype-specific, fluorochrome-labeled (A488, A568, A647) goat anti–mouse immunoglobu-
lin antibodies (Molecular Probes) for 90 minutes. Controls included staining with isotype-matched antibodies. 
Nuclei were stained with DAPI. Immunofluorescence of skin sections was examined using a Leica-TCS-SP MP 
inverted single confocal laser-scanning and a 2-photon laser microscope (Leica) at the Advanced Microscopy/
Spectroscopy Laboratory Macro-Scale Imaging Laboratory (California NanoSystems Institute, UCLA).
Transmission electron microscopy. Human LCDC were fixed with 2% paraformaldehyde and 2.5% glu-
taraldehyde (Electron Microscopy Sciences) in 1× PBS (Gibco), pH 7.35, for 1 hour at room temperature 
and stored at 4°C overnight. The cell pellets were washed with PBS, embedded in 4% low-melt agarose, 
cut into small pieces, and post-fixed with 1% OsO4 in ddH2O. Following washing with ddH2O, the cells 
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were stained en bloc with 2% uranyl acetate, washed, dehydrated through a graded series of  ethanol, 
treated with propylene oxide, and embedded in Eponate 12 (Ted Pella Inc.). Silver to gold interference 
color sections were cut on a TMC ultramicrotome and picked up on formvar-coated copper grids. The 
sections were stained with Reynolds lead citrate and examined on a JEOL 100CX electron microscope at 
60 kV. Images were collected on type 4489 EM film, and the negatives were digitized at 1200 dpi. Adobe 
Photoshop was used to quantify the pixel area of  cellular compartments. The volume fractions of  images 
were calculated by dividing the sum of  the area occupied by of  single- or double-membrane autophagic 
compartments with the area of  the cell (64).
Immunoblotting analysis. LCDC, 1 × 106 per condition, were collected in NP-40 lysis buffer (50 mM 
Tris [pH 7.4], 50 mM NaCl, 5 mM EDTA, 50 mM NaF, 1 mM Na3VO4, 1% Nonidet P40 [NP40],0.02% 
NaN3 and 1 mM PMSF) containing complete protease inhibitors (Roche Applied Science). Total protein 
from cell lysates were quantified using Bradford Assay. Lysates were separated on a 7.5% nondenaturing 
gel, followed by immunoblot analysis with anti–β-actin and anti-LC3 (see Reagents above) and detected by 
enhanced chemiluminescence (Pierce Biotechnology).
CD1a-restricted T cell clone. An M. leprae–reactive CD4+ T cell line (LCD4.G) was derived from a biopsy 
of  a skin lesion from an untreated patient with T-lep as described (24). To obtain supernatants, 1 × 106 
T cells were cultured in 1 ml of  media containing 10% FCS with or without the addition of  CD3/CD28 
Dynabeads, with a bead/cell ratio of  1:1. Supernatants were collected after 24 hour stimulation and stored 
at –80°C. IFN-γ levels of  T cell supernatants were measured by sandwich ELISA.
Antigen presentation and proliferation assay. LCD4.G is a CD4+ T cell line derived from a tuberculoid 
lesion as described (24). T cells were maintained by serial antigenic stimulation using LCDC in medium 
supplemented with recombinant IL-2. Antigen presentation by LC was measured using a suboptimal 
ratio of  0.1 LC to 1.0 T cell, instead of  1:1, in order to measure both inhibition and augmentation of  
the T cell response. Epidermal LC and LCDC were pretreated with 10 ng/ml of  IFN-γ in 10% human 
serum overnight. The cells were washed prior to the overnight infection with M. leprae at a MOI of  10 in 
10% FCS. Extracellular bacteria were removed by vigorous washing. The infected cells were then treated 
again with the same concentration of  IFN-γ for 2 hours, and they were washed again to remove IFN-γ 
prior to coculture with T cells. For measurement of  T cell proliferation, 1 × 104 T cells were cultured 
with 1 × 103 uninfected-LCDC (MED) or mLEP-LC (MOI 10) in 10% human serum. T cells were also 
cultured with 100 U/ml of  IL-2 as positive control. Following 4 days of  culture in 96-well plates in trip-
licate at 37°C in a 4% CO2 incubator, cells were pulsed with 
3H-thymidine (1 μCi/well; ICN Biomedicals 
Inc.) and harvested 4 hours later for liquid scintillation counting. To validate the CD1a restriction of  
the T cell lines, neutralizing CD1a monoclonal antibodies (20 μg/ml) were added 30 minutes before 
the addition of  T cells. Alternately, 1 × 104 T cells were cultured with 1 × 103 M. leprae–infected mono-
cyte-dervived-macrophage. Following 4 days of  culture in 96-well plates in triplicate at 37°C in a 4% 
CO2 incubator, cells were pulsed with 
3H-thymidine (1 μCi/well; ICN Biomedicals Inc.) and harvested 4 
hours later for liquid scintillation counting.
Statistics. Statistics reported are of  entire series of  experiments and described as mean ± SEM. Graph-
Pad Prism 6 software was used for graphing and statistical analysis. For comparison between 3 or more 
groups, we utilized repeated measures 1-way ANOVA, with the Greenhouse-Geisser correction, along with 
Tukey’s multiple comparisons test, with individual variances computed for each comparison. The 2-tailed 
Student’s t test was used for all other 2-group analysis. A P value less than 0.05 was considered significant.
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the Institutional Ethics Committee of  Oswald Cruz Foundation, as well as UCLA.
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